Scientific Research News

POWAY, Calif.--(BUSINESS WIRE)--StratEdge receives a 2025 BAE Systems Partner 2 Win Gold Tier Award for strong performance and contributions to the Electronic Systems supply chain....

IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)--Multivariate analyses reveal that pCR is associated with transcriptomic differences and chemotherapy type, rather than self-reported race...

LOS ANGELES & ATLANTA--(BUSINESS WIRE)--Sequenex today announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies. MedTech Innovator matches healthcare industry leaders with innovative early-stage medtech companies for mentorship and support. In 2026, MedTech Innovator will select 65 startups for participation in its program. Sequenex will work directly with select emerging companies and will also provide financial support to MedTech...

NEW YORK--(BUSINESS WIRE)--Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have completed the sale of Noramco, Extractas Biosciences, and Purisys of the Noramco Group (“Noramco” or the “Company”) to Siegfried Holding AG (SIX: SFZN; “Siegfried”), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry....

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference...

DEL MAR, Calif.--(BUSINESS WIRE)--Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced it will present new data related to a prespecified subgroup analysis in children with fast-progressing myopia from the Phase 3 STAR trial of SYD-101 at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting taking place May 3-7, 2026 in Denver, Colorado. Presentation Details...

AMSTERDAM--(BUSINESS WIRE)--Nebius (NASDAQ: NBIS), the AI cloud company, today announced an agreement to acquire Eigen AI, a leading inference and model optimization company. The acquisition will strengthen Nebius Token Factory as a frontier managed inference platform for production AI, combining a battle-tested optimization stack with Nebius’s global compute capacity and AI cloud platform, and will add elite inference research talent to the company’s established in-house AI R&D capabilitie...

BOSTON--(BUSINESS WIRE)--Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering...

WILMINGTON, Del.--(BUSINESS WIRE)--The US Food and Drug Administration’s (FDA) Oncologic Drugs Advisory Committee (ODAC) has recognized a favorable benefit risk profile for AstraZeneca’s TRUQAP® (capivasertib) in combination with abiraterone and androgen deprivation therapy (ADT) for the treatment of patients with PTEN-deficient metastatic hormone-sensitive prostate cancer (mHSPC), based on the CAPItello-281 Phase III trial. The Committee voted 7 to 1, with 1 abstaining. In August 2025, the FDA...

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on clinical and operational progress for the first quarter ended March 31, 2026. Clinical & Operational Updates Operational progress continues with ivonescimab (SMT112), an investigational, potentially first-in-class bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects ass...